Many imaging and serologic tests have been evolved to help predict the occurrence of congenital disease. One such test is the maternal serum alpha-fetoprotein screening test (MS-AFP). The MS-AFP test ...

Abbott announced that the FDA has approved Architect AFP, a test to help detect serious birth defects and the progression of testicular cancer. Alpha-fetoprotein (AFP) is a biomarker that can identify ...

Post-hoc analyses of AFP response and progression and their relationship with objective measures of response and survival were performed in patients from REACH. Serum AFP was measured at baseline and ...

ABBOTT PARK, Ill., March 28, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the ARCHITECT AFP test, which may help doctors detect serious birth defects and the progression of testicular ...

The objective of this study was to evaluate the efficacy of IGFBP-1/AFP (insulin-like growth factor-binding protein-1/alpha-fetoprotein) immunoassay (Amnioquick Duo+) in diagnosing rupture of ...

A race-based adjustment to test-result values from a common prenatal screening should be discontinued, according to a study published this week in Obstetrics and Gynecology. The adjustment has ...

Retrospective analysis of systemic chemotherapy for unresectable advanced biliary tract cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO ...